Last reviewed · How we verify

Control group: Mesalazine enema treatment

Beijing Hospital of Traditional Chinese Medicine · Phase 1 active Small molecule Quality 0/100

Control group: Mesalazine enema treatment is a Small molecule drug developed by Beijing Hospital of Traditional Chinese Medicine. It is currently in Phase 1 development. Also known as: Mesalazine enema is produced by Vifor AG Zweigniederlassung Medichemie Ettingen, National medicine approval H20150127..

At a glance

Generic nameControl group: Mesalazine enema treatment
Also known asMesalazine enema is produced by Vifor AG Zweigniederlassung Medichemie Ettingen, National medicine approval H20150127.
SponsorBeijing Hospital of Traditional Chinese Medicine
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Control group: Mesalazine enema treatment

What is Control group: Mesalazine enema treatment?

Control group: Mesalazine enema treatment is a Small molecule drug developed by Beijing Hospital of Traditional Chinese Medicine.

Who makes Control group: Mesalazine enema treatment?

Control group: Mesalazine enema treatment is developed by Beijing Hospital of Traditional Chinese Medicine (see full Beijing Hospital of Traditional Chinese Medicine pipeline at /company/beijing-hospital-of-traditional-chinese-medicine).

Is Control group: Mesalazine enema treatment also known as anything else?

Control group: Mesalazine enema treatment is also known as Mesalazine enema is produced by Vifor AG Zweigniederlassung Medichemie Ettingen, National medicine approval H20150127..

What development phase is Control group: Mesalazine enema treatment in?

Control group: Mesalazine enema treatment is in Phase 1.

Related